A New Generation of Biomarkers for Detecting Early Signs of Kidney Damage
Nephrotoxicity is a major problem in the preclinical and clinical setting that results in the failure of candidate compounds throughout the drug-devel...
S100A12 (EN-RAGE) Correlates with Poor Outcome after Ischemic Stroke
Researchers published data illustrating the potential utility of S100A12 (EN-RAGE) as a predictive biomarker of functional outcome after ischemic stro...
Biomarkers of Concussion May Speed Diagnosis
Traumatic brain injuries and concussions are rather common in contact sports, resulting in a variety of symptoms including dizziness, headaches, nause...
Establishing the boundaries of a healthy immune response
New research published in Immunity describes a standardized method to reproducibly measure a functional immune response in healthy donors. Conducted b...
Biomarkers for Alzheimer’s Continue to Offer Hope
As the population ages and the number of individuals diagnosed with Alzheimer's rises, there is an ever increasing need for earlier diagnosis. Detecti...
Fibrinogen Identified as a Prognostic Biomarker for Malignant Pleural Mesothelioma (MPM)
MPM is a treatment-resistant disease pathogenically related to chronic inflammation. Research recently published in the British Journal of Cancer conc...
Biomarkers Validated for Acute Kidney Injury (AKI)
A clinical test measuring tissue inhibitor of metalloproteinases (TIMP)-2 and insulin-like growth factor binding protein 7 (IGFBP7) in urine has been...